Joel Goode

Joel Goode is a seasoned executive in the biopharmaceutical industry with extensive experience in leadership roles across various companies. Currently serving as Zone Business Director at Sanofi Genzyme since March 2018, Joel focuses on creating high-performance teams and driving patient-centered engagement in biologic launches. Prior roles include Regional Business Director at Achaogen, where Joel contributed to the commercialization of innovative antibacterials, and Vice President at The Medicines Company, advancing care solutions in acute circumstances. Previously, Joel held multiple leadership positions at Gilead Sciences, leading strategies for cardiopulmonary treatments and managing significant account portfolios. Joel began a career in sales at GlaxoSmithKline, providing therapeutic solutions in the CNS and GI fields. Joel holds a BA in Business Administration with a focus on Marketing and Management from the University of North Florida.